Autoimmune Afib; Inappropriate ICD Shocks Down; Dissolving Cardiac Sensors

— Recent developments of interest in cardiovascular medicine

MedicalToday
Cardio Break over a computer rendering of a heart.

FDA approved expanded use of atop its existing indications of atherosclerotic cardiovascular and heterozygous familial hypercholesterolemia, Novartis announced.

An estimate gives users of an extra 2 years free of myocardial infarction, stroke, or cardiovascular death in a lifetime. (European Journal of Preventive Cardiology)

A mouse model supports the existence of an . (Circulation)

New produced slightly higher voltages that were helpful for guiding ventricular tachycardia ablation. (HeartRhythm)

In Denmark, people with congenital heart disease are prone to (OHCA), with typical odds of survival. (European Heart Journal)

Bystander response and OHCA survival rates were improved with activation of in several European regions. (Journal of the American College of Cardiology)

Contemporary implantable cardioverter-defibrillators carry a , at 1.6% in 2 years, based on postmarketing data. (EP Europace)

The was identified as having a role in whether a person develops a bicuspid aortic valve. (JAMA Cardiology)

One-year outcomes of taking direct oral anticoagulants or vitamin K antagonists were comparable in a real-world German population. (Heart)

An artificial intelligence model has been taught to identify low ejection fraction and based on chest X-rays. (The Lancet Digital Health)

Separate from socioeconomic status, was independently associated with cardiovascular outcomes. (JAMA Network Open)

Black women with a history of hypertensive disorders of pregnancy have an estimated . (NEJM Evidence)

performed comparably to alteplase in the subset of stroke patients with large vessel occlusions in the ACT trial. (JAMA Neurology)

At least , people still had excess emergency visits or hospitalizations for cardiovascular diagnoses, according to records from Alberta, Canada. (JACC: Advances)

Health Canada declared a , forcing patients to put off myocardial perfusion scans. (CBC News)

Four years after lower-extremity femoropopliteal peripheral intervention for intermittent claudication, the incidence of repeat revascularization rose to 16.7%, and (JACC: Cardiovascular Interventions)

Scientists report how they created a , roughly the size of a postage stamp, that can temporarily perform electrical mapping and pacing. (Science Advances)

Researchers found that can hinge on reduced responsiveness of cardiac pacemaker cells. (PNAS)

  • author['full_name']

    Nicole Lou is a reporter for , where she covers cardiology news and other developments in medicine.